M.S in chemical engineering
United States of America
Peter Dansky has served as Chief Executive Officer and a member of the Board of Directors of Agena Bioscience since July 2014. From 2013 to 2014, Peter was CEO of iGenomX, an early stage next generation sequencing company. From 2008 to 2013, he was President of Life Technologies’ Molecular & Cell Biology and Molecular Biology Systems divisions.